Poster Award

P.1423
Psilocybin vs escitalopram for depression: 6-month follow-up
Tommaso Barba, United Kingdom  

P.1232 Safety and efficacy of a cross-correction-based gene therapy approach for CDKL5 deficiency disorder
Giulia Candini, Italy

P.1040 Prediction of attention-deficit/hyperactivity disorder methylphenidate treatment response using volume-based and Radiomics-based T1 and ᠎᠎᠎diffusion tensor imaging features
Mingshi Chen, The Netherlands

P.2212 Cerebrospinal fluid synaptic biomarkers in a large cross-disorder cohort of psychiatric disorders
Andreas Göteson, Sweden

P.1087 From bungee jumps to depression slumps: an investigation into the interplay between stress and autophagy
Yara Mecdad, Germany

P.2137 AI-Based prediction of depression symptomatology in first episode psychosis patients: insights from the EUFEST and RAISE clinical trial
Sergio Mena Ortega, United Kingdom

P.3239 Cortical thickness alterations and systemic inflammation define long-Covid patients with cognitive impairment
Tonia Rocktäschel, Germany

P.3515 Disrupting microbiota composition and microbiota-gut-brain signalling: impacts on reward, motivation, and decision-making.
Brendan Sharvin, Ireland

P.2297 Sleep-related polygenic scores and multi-polygenic score approach to lithium response prediction in bipolar disorder
Marina Zafrilla López, Spain

P.0624
The impact of cognitive reserve on cognition, connectome pathology, and disease course in depression
Marius Gruber, Germany

P.0627
Contrasting genetic burden for bipolar disorder: early onset versus late onset in an older adults bipolar disorder (OABD) sample
Laura Montejo, Spain

P.0628
A novel dual-site orbitofrontal-dorsal lateral prefrontal cortex accelerated repetitive transcranial magnetic stimulation for depression – a pilot randomised controlled study
Hailun Cui, United Kingdom

P.0572
Cognitive and neural correlates of capsulotomy in obsessive-compulsive disorder
Yi-Jie Zhao, China

P.0542
Maternal high-fat diet-induced microbial changes are associated with altered foetal brain metabolome, plasticity and adolescent behaviour
Anna Ratsika, Ireland

P.1267
Detecting common mental disorders in the global south using accessible and interpretable machine learning: a multi-center study in Brazilian longitudinal study of adult health cohort
Sen Dong, Germany

P.0143
Moving beyond clinical approaches: machine learning on neuroimaging and cognitive features for the differential diagnosis between unipolar and bipolar depression
Elisa Serra, Luxembourg

P.1191
The effect of adverse childhood experiences on theory of mind brain networks: association with clinical and behavioural outcomes in schizophrenia
Alice Pelucchi, Italy

P.0334
Effects of psychedelics on induced pluripotent stem cells — derived neurons
Deborah Reyes, United Kingdom

P.0009
Striatal cerebral blood flow changes in patients with recent-onset bulimia nervosa and alcohol use disorder
Nicolas Leenaerts, Belgium
Addiction; Eating disorders; In vivo neuroimaging

P.0021
Deficiency of Cadherin 13, a ADHD risk gene, impacts serotonergic circuit formation and cognitive function in mice
Hsing-Ping Ku, Germany
ADHD; Animal models and related methods

P.0072
Anxious distress in major depression: an fMRI study of amygdala reactivity and functional connectivity
Laura Nawijn, The Netherlands
Mood disorders; Anxiety and Anxiety disorders; In vivo neuroimaging

P.0085
Predicting depression onset in young people based on clinical, cognitive, environmental and neurobiological data
Yara Toenders, The Netherlands
Mood disorders; Biostatistics and computational methods

P.0252
N-acetylcysteine supplement during pregnancy may prevent some of the behavioral and neuroanatomical deficits in a schizophrenia-like rat model
Diego Romero-Miguel, Spain
Animal models and related methods; In vivo neuroimaging; Psychotic disorders

P.0422
CLOCK gene variation mediates effect of early childhood adversities and recent stressors on current depressive symptoms
Dorka Győrik, Hungary
Mood disorders; Stress-related disorders; Genetics and molecular approaches

P.0554
Effect of paroxetine discontinuation on 5-HT neurochemistry in mice ex vivo and in vivo
Helen Collins, United Kingdom
Animal models and related methods; Mood disorders; Pharmacology

P.0766
Sex differences in hippocampal subfield volumes and relationship to testosterone measures in schizophrenia and bipolar disorders
Claudia Barth, Norway
Psychotic disorders; In vivo neuroimaging

P.0883
Immune signature of multiple sclerosis-associated depression
Jelena Brasanac, Germany
Immunology; Mood disorders; Neuro-inflammatory/auto-immune

P.070
Melatonin MT2 receptors modulate anhedonic behaviour and circadian temperature rhythm
Rosa Tordera, Spain

P.639
The individual’s personal experience of the living environment affects serotoninergic antidepressant treatment outcome
Naomi Ciano Albanese, Italy

P.188
DNA methylation changes of NR3C1 and SLC6A4 are associated with blunted stress reactivity in depression
Jelena Bakusic, Belgium

P.253
Immunoassay quantification and neuroimaging data for differentiating bipolar and unipolar depression: support vector machine on kernels and elastic net approaches
Benedetta Vai, Italy

P.254
Comprehensive evaluation of the analytic pipelines for major depressive disorder classifier based on resting state fMRI
Yuji Takahara, Japan

P.282
Hippocampal volume changes are linked to depressive symptoms independent of sex-steroid hormone manipulation: a pharmacological structural MRI study
Camilla Borgsted Larsen, Denmark

P.804
A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain
Nakul Ravi Raval, Denmark

P.525
The relationship between synaptic density marker SV2A and glutamate: a multimodal positron emission tomography and magnetic resonance spectroscopy imaging study
Ellis Chika Onwordi, United Kingdom

P.773
Therapeutic potential of bromelain in 6-hydroxydopamine rat model of parkinson's disease
Betül Çiçek, Turkey

P.132
Amphetamine-induced dopamine release and its relationship to impulsiveness: A [11C]-(+)-PHNO study in healthy subjects
Weidenauer Ana, Austria
Addiction - Disorder; Pharmacology - Method; Neuroimaging - Method

P.188
Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality
Madsen Martin Korsbak, Denmark
Neuroimaging - Method; Neuromodulation - Intervention; Pharmacology - Intervention

P.195
Neurobiological basis for the development of dopaminergic strategies to rescue deficient fear extinction
Sartori Simone B., Austria
Anxiety - Disorder; Pharmacology - Intervention; Psychotherapy - Intervention

P.352
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
Koehler-Forsberg Kristin, Denmark
Mood and bipolar disorder; Pharmacology - Intervention

P.401
Exploring the impact of iatrogenic factors on global brain changes in long-term treated chronic schizophrenia – a 13-years follow-up
Barth Claudia, Norway
Psychotic disorder; Neuroimaging - Method

P.509
Continual oxytocin treatment induces long-lasting adaptations within amygdala circuitry in autism: a randomized placebo-controlled trial
Alaerts Kaat, Belgium
Autism/ASD - Disorder; Neuroimaging - Method; Pharmacology - Intervention

P.585
Differential effects of psychotropic drugs on microbiome composition
Cussotto Sofia, Ireland
Animal models - Method; Mood and bipolar disorder; Pharmacology - Intervention

P.787
Prefrontal cortical thickness is associated with response to cognitive-behavioural therapy in children and adolescents with OCD
Bertolín Triquell Sara, Spain
Neuroimaging - Method; Anxiety - Disorder; Psychotherapy - Intervention

P.845
Striatal structural covariance in obesity and its relationship with the bacterial microbiome
De La Peña Arteaga Victor, Spain
Eating disorder; Neuroimaging - Method

P.093
Age at first episode modulates progressive cortical thinning in individuals with psychosis
Pina-Camacho Laura, Spain
Psychotic disorder; Neuroimaging - Method

P.124
Imbalance in the deployment of neural resources during visual working memory encoding in schizophrenia as a possible intermediate phenotype
Stäblein Michael, Germany
Psychotic disorder; Neuroimaging - Method; Neuropsychology - Method

P.225
Rapid anxiolytic effects of 5-HT4 receptor agonist involves prefrontal cortex-brainstem neural circuit recruitment
Faye Charlene, France
Anxiety - Disorder; Animal models - Method; Pharmacology - Intervention

P.228
The effects of relaxin-3 knock down neurons on body weight and food intake in female rats
De Avila Dal'bo Camila, Canada
Eating disorder; Stress related disorder; Anxiety - Disorder

P.545
The early antidepressant-like effect of deep brain stimulation: patterns of activity and their modulation by analgesics
Perez Caballero Laura, Spain
Mood and bipolar disorder; Animal models - Method

P.759
Early-life stress affects microglia, possible modulation by dietary fatty acids
Reemst Kitty, The Netherlands
Stress related disorder; Neuro-inflammatory disorder; Lifestyle and nutrition – Intervention

P.777
Increased perseverative errors during probabilistic reversal learning using cathodal high definition transcranial current stimulation
Albein-Urios Natalia, Australia
Neuromodulation - Intervention; Healthy brain

P.849
Microarray study of the effects of a chronic high-fat diet on a brain-specific interleukin-6-deficient mouse
Fernandez Gayol Olaya, Spain
Genetic & molecular approaches - Method; Animal models - Method; Biostatistics & computational method